Pharmacokinetics and other risk factors for kanamycin-induced hearing loss in patients with multi-drug resistant tuberculosis

OBJECTIVE: The toxicity associated with the use of kanamycin includes irreversible hearing loss. There is limited data describing the relationship between hearing loss and kanamycin pharmacokinetics (PK). We explored the association of kanamycin PK with hearing loss in patients on MDR-TB treatment....

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Int J Audiol
मुख्य लेखकों: Ghafari, Nazanin, Court, Richard, Chirehwa, Maxwell Tawanda, Wiesner, Lubbe, Petersen, Lucretia, Maartens, Gary, Gumbo, Tawanda, McIlleron, Helen, Ramma, Lebogang
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2019
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7582222/
https://ncbi.nlm.nih.gov/pubmed/31739701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14992027.2019.1690170
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन